Schiller Howard Bradley
Insider CIK 1536053 · VRX EVP, Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2016-02-18 | 2016-02-22 | 51,846 | $91.45 | $4.74M | 336,784 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2016-02-18 | 2016-02-22 | 2,245 | $91.45 | $205.3K | 388,630 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-07-01 | 2016-01-04 | 1,506 | — | $0 | 590,875 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-04-27 | 2015-04-28 | 22,500 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-04-27 | 2015-04-28 | 4,859 | — | $0 | 289,369 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-04-27 | 2015-04-28 | 11,779 | — | $0 | 294,228 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-04-27 | 2015-04-28 | 22,500 | — | $0 | 306,007 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-01-26 | 2015-01-28 | 11,607 | — | $0 | 283,507 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-01-05 | 2015-01-07 | 45,000 | — | $0 | 22,500 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-01-05 | 2015-01-07 | 45,000 | — | $0 | 318,714 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-01-05 | 2015-01-07 | 23,600 | — | $0 | 295,114 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2014-12-01 | 2014-12-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-10-03 | 2014-10-07 | 22,500 | — | $0 | 67,500 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-10-03 | 2014-10-07 | 11,786 | — | $0 | 273,714 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-10-03 | 2014-10-07 | 22,500 | — | $0 | 285,500 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-04-28 | 2014-04-30 | 4,849 | $122.05 | $591.8K | 263,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-02-11 | 2014-02-12 | 90,000 | — | $0 | 90,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-02-11 | 2014-02-12 | 90,000 | — | $0 | 312,704 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-02-11 | 2014-02-12 | 44,855 | — | $0 | 267,849 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-01-20 | 2014-01-22 | 3,000 | — | $0 | 222,704 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-01-20 | 2014-01-22 | 8,284 | — | $0 | 225,704 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-08-16 | 2013-08-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-08-16 | 2013-08-16 | 90,000 | — | $0 | 279,218 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-08-16 | 2013-08-16 | 45,230 | — | $0 | 233,988 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-04-20 | 2013-04-23 | 4,805 | — | $0 | 189,218 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-01-20 | 2013-01-22 | 18,300 | — | $0 | 201,200 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-01-20 | 2013-01-22 | 7,177 | — | $0 | 194,023 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-11-06 | 2012-11-08 | 18,300 | $54.10 | $990.0K | 182,900 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-04-20 | 2012-05-18 | 27,800 | — | $0 | 164,600 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-03-06 | 2012-03-08 | 9,200 | $53.53 | $492.5K | 136,800 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-03-02 | 2012-03-05 | 9,300 | $53.81 | $500.4K | 127,600 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-03-01 | 2012-03-05 | 9,300 | $53.47 | $497.3K | 118,300 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-01-20 | 2012-01-24 | 54,500 | — | $0 | 109,000 | SEC↗ |